Cargando…
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
Chemotherapy-induced cognitive impairment (CICI) is a commonly reported neurotoxic side effect of chemotherapy, occurring in up to 75% cancer patients. CICI manifests as decrements in working memory, executive functioning, attention, and processing speed, and greatly interferes with patients’ daily...
Autores principales: | Ma, Jiacheng, Huo, XiaoJiao, Jarpe, Matthew B., Kavelaars, Annemieke, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166273/ https://www.ncbi.nlm.nih.gov/pubmed/30270813 http://dx.doi.org/10.1186/s40478-018-0604-3 |
Ejemplares similares
-
Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice
por: Huo, XiaoJiao, et al.
Publicado: (2018) -
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016) -
HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling
por: Zhang, Jixiang, et al.
Publicado: (2022) -
Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy
por: Maj, Magdalena A., et al.
Publicado: (2017) -
HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity
por: McAlpin, Blake R, et al.
Publicado: (2022)